Novo Nordisk tests 0.786 Arc – Awaiting directional confirmation

Novo Nordisk A/S class B (NOVO_B): Arc cycle analysis

Overview: Based on Arc Cycle Analysis applied to the 2h chart, Novo Nordisk is interacting with the 0.786 Arc within the current Arc Cycle. Price remains centered around this Arc, indicating that directional confirmation has not yet been established.

Market outlook

Price remains centered around the 0.786 Arc, indicating that the market has not yet established a directional bias within the current Arc Cycle. The preferred approach is to await confirmation before anticipating the next significant move.

A sustained 2h close above would favor continued movement toward 303.00 price, while a sustained close below the 2h would shift the outlook toward 287.00 price.